Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions.
作者信息
Green Philip, Maurer Mathew S, Foody Joanne M, Forman Daniel E, Wenger Nanette K
出版信息
J Am Coll Cardiol. 2012 Aug 28;60(9):869-71. doi: 10.1016/j.jacc.2012.03.034. Epub 2012 May 30.
Abstract
摘要
相似文献
1
Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions.在2011年美国心脏协会科学会议的最新临床试验中老年人的代表性。
J Am Coll Cardiol. 2012 Aug 28;60(9):869-71. doi: 10.1016/j.jacc.2012.03.034. Epub 2012 May 30.
2
Report of the American Heart Association (AHA) Scientific Session 2017, Anaheim, California.美国心脏协会（AHA）科学会议 2017 年报告，加利福尼亚州阿纳海姆。
Circ J. 2018 Jan 25;82(2):323-327. doi: 10.1253/circj.CJ-17-1387. Epub 2018 Jan 11.
3
Report of the American Heart Association (AHA) Scientific Sessions 2013, Dallas.2013 年美国心脏协会（AHA）科学会议报告，达拉斯。
Circ J. 2014;78(1):51-6. doi: 10.1253/circj.cj-13-1466. Epub 2013 Dec 13.
4
American Heart Association 2014 Scientific Sessions.美国心脏协会2014年科学会议
J Diabetes. 2015 May;7(3):299-301. doi: 10.1111/1753-0407.12271. Epub 2015 Mar 24.
5
Highlights of the latest clinical trials from the 2010 Scientific Sessions of the American Heart Association.美国心脏协会2010年科学会议上最新临床试验的要点。
Future Cardiol. 2011 Mar;7(2):163-7. doi: 10.2217/fca.11.4.
6
Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association.2008年美国心脏协会科学会议上热线会议的要点。
Clin Res Cardiol. 2009 Jan;98(1):1-7. doi: 10.1007/s00392-008-0742-x. Epub 2008 Dec 12.
7
8
Imaging highlights of the American Heart Association 2007 scientific sessions.美国心脏协会2007年科学会议的影像学亮点。
JACC Cardiovasc Imaging. 2008 Mar;1(2):252-62. doi: 10.1016/j.jcmg.2008.01.012.
9
引用本文的文献
1
Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: Insights From Publications Between 2011 and 2020.亚太地区研究者与亚洲人群参与心血管代谢试验情况：2011年至2020年出版物见解
JACC Asia. 2023 Jul 4;3(5):724-735. doi: 10.1016/j.jacasi.2023.05.010. eCollection 2023 Oct.
2
Disparities by sex in P2Y inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y inhibitor new user retrospective cohort analysis of US Medicare claims data.在急性心肌梗死后，老年女性与可比男性相比，P2Y 抑制剂治疗持续时间是否存在性别差异，或者缺血获益和出血风险临床结局的平衡是否存在差异？利用美国医疗保险索赔数据的 P2Y 抑制剂新使用者回顾性队列分析。
BMJ Open. 2021 Dec 1;11(12):e050236. doi: 10.1136/bmjopen-2021-050236.
3
Inclusion of Older People Reflective of Real-World Clinical Practice in Cardiovascular Drug Trials.心血管药物试验纳入老年人反映了真实世界的临床实践。
J Am Heart Assoc. 2020 Nov 3;9(21):e016936. doi: 10.1161/JAHA.120.016936. Epub 2020 Oct 26.
4
Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.老年急性心肌梗死后应用血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体阻滞剂患者发生严重不良事件的发生率和危险因素。
Pharmacotherapy. 2018 Jan;38(1):29-41. doi: 10.1002/phar.2051. Epub 2017 Dec 11.
5
Time for a New Approach to Studying Older People with Ischemic Heart Disease.是时候采用新方法研究老年缺血性心脏病患者了。
J Am Geriatr Soc. 2017 Nov;65(11):2349-2351. doi: 10.1111/jgs.14923. Epub 2017 May 11.
6
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.老年人群心血管护理中的知识空白：美国心脏协会、美国心脏病学会和美国老年医学会的科学声明。
J Am Coll Cardiol. 2016 May 24;67(20):2419-2440. doi: 10.1016/j.jacc.2016.03.004. Epub 2016 Apr 11.
本文引用的文献
1
Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States.美国≥85 岁患者行经皮冠状动脉介入治疗和药物洗脱支架的使用情况。
J Am Coll Cardiol. 2012 Jan 10;59(2):105-12. doi: 10.1016/j.jacc.2011.10.853.
2
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.《2012年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
3
Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy.秋水仙碱可减少术后心房颤动：秋水仙碱预防心包切开术后综合征（COPPS）心房颤动亚研究的结果。
Circulation. 2011 Nov 22;124(21):2290-5. doi: 10.1161/CIRCULATIONAHA.111.026153. Epub 2011 Nov 16.
4
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.依泽替米贝单药治疗或与他汀类药物联合治疗对高密度脂蛋白胆固醇和低密度脂蛋白胆固醇的影响：一项随机对照试验。
JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649.
5
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.基于 CYP2C19 基因型的氯吡格雷剂量调整与稳定型心血管疾病患者血小板反应性的关系。
JAMA. 2011 Nov 23;306(20):2221-8. doi: 10.1001/jama.2011.1703. Epub 2011 Nov 16.
6
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.缺血性心肌病患者的心脏干细胞（SCIPIO）：一项随机 1 期试验的初步结果。
Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14.
7
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.烟酸在接受强化他汀类药物治疗的低 HDL 胆固醇水平患者中的应用。
N Engl J Med. 2011 Dec 15;365(24):2255-67. doi: 10.1056/NEJMoa1107579. Epub 2011 Nov 15.
8
Comparative effectiveness of weight-loss interventions in clinical practice.临床实践中减肥干预措施的效果比较。
N Engl J Med. 2011 Nov 24;365(21):1959-68. doi: 10.1056/NEJMoa1108660. Epub 2011 Nov 15.
9
Effect of two intensive statin regimens on progression of coronary disease.两种强化他汀类药物治疗方案对冠状动脉疾病进展的影响。
N Engl J Med. 2011 Dec 1;365(22):2078-87. doi: 10.1056/NEJMoa1110874. Epub 2011 Nov 15.
10
Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.药师在初级保健中干预以改善左心室收缩功能障碍患者的结局。
Eur Heart J. 2012 Feb;33(3):314-24. doi: 10.1093/eurheartj/ehr433. Epub 2011 Nov 14.
Zotero 插件